Hyundai Bioscience announced that CNPharm, its major shareholding biotech company, has succeeded in developing 'Poly-COV01,' an injection drug for the potential treatment of patients ... Dec 23
Converge Biotech, today announces the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ and is indicated for ... Aug 04
-Advertisements-